Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Am J Transplant. 2017 May 30;17(11):2911–2921. doi: 10.1111/ajt.14310

Table 5.

Associations of thyroid cancer with underlying medical indication for transplant among kidney and liver recipients

Total thyroid cancer Papillary carcinoma Local Regional/distant
Indication for transplant Cases IRR (95%CI)a Cases IRR (95%CI)a Cases IRR (95%CI)a Cases IRR (95%CI)a
Kidney recipients
 Glomerular diseases 73 0.97 (0.75–1.27) 67 0.97 (0.74–1.28) 56 1.13 (0.83–1.55) 16 0.74 (0.44–1.25)
 Diabetes mellitus 36 0.78 (0.56–1.09) 27 0.65 (0.44–0.94) 23 0.76 (0.50–1.16) 11 0.80 (0.44–1.47)
 Hypertensive nephrosclerosis 45 1.41 (1.03–1.94) 43 1.50 (1.08–2.07) 30 1.38 (0.93–2.05) 12 1.39 (0.77–2.54)
 Polycystic kidney disease 21 0.78 (0.51–1.17) 20 0.81 (0.53–1.24) 13 0.74 (0.44–1.25) 6 0.77 (0.36–1.67)
 Tubular and interstitial diseases 16 1.00 (0.63–1.58) 16 1.08 (0.68–1.72) 12 1.13 (0.66–1.94) 4 0.89 (0.36–2.19)
 Vascular diseases 11 1.37 (0.80–2.36) 9 1.25 (0.69–2.27) 9 1.69 (0.91–3.11) 2 0.90 (0.26–3.13)
 Congenital/familial/metabolic disorders 6 0.83 (0.40–1.73) 6 0.90 (0.43–1.87) 3 0.62 (0.22–1.73) 3 1.47 (0.50–4.29)
 Other/unknown conditions 29 1.06 (0.74–1.51) 27 1.08 (0.74–1.56) 17 0.95 (0.60–1.52) 11 1.35 (0.74–2.46)
Liver recipients
 Cholestatic liver disease/cirrhosis 14 1.69 (1.09–2.63) 12 1.58 (0.99–2.54) 9 1.66 (0.95–2.88) 4 1.73 (0.77–3.89)
 Noncholestatic cirrhosis 26 0.81 (0.56–1.18) 23 0.81 (0.55–1.21) 16 0.79 (0.50–1.27) 10 1.04 (0.54–2.03)
 Other/unknown conditions 13 0.73 (0.46–1.15) 12 0.78 (0.48–1.25) 8 0.76 (0.43–1.35) 4 0.55 (0.24–1.29)

Abbreviations: CI, confidence interval; IRR, incidence rate ratio

a

IRRs were adjusted for attained age, sex, race/ethnicity, transplanted organ, time since transplant, and year of transplantation and were modeled using effect parameterization, which compares each category to the average of all of the categories.